At a Glance: In this episode of Lab Medicine Rounds, Sounak Gupta, M.B.B.S., Ph.D., assistant professor of Laboratory Medicine and ... Comparative analysis of RNA expression identifies druggable targets in difficult-to-treat pediatric

Hereditary Oncology Molecular Testing For Solid Tumors -

In this episode of Lab Medicine Rounds, Sounak Gupta, M.B.B.S., Ph.D., assistant professor of Laboratory Medicine and ... Comparative analysis of RNA expression identifies druggable targets in difficult-to-treat pediatric Program presented by: Porscha Johnson, PharmD, CPGx This video was recorded in June 2023.

Important details found

  • In this episode of Lab Medicine Rounds, Sounak Gupta, M.B.B.S., Ph.D., assistant professor of Laboratory Medicine and ...
  • Comparative analysis of RNA expression identifies druggable targets in difficult-to-treat pediatric
  • Program presented by: Porscha Johnson, PharmD, CPGx This video was recorded in June 2023.

Why this topic is useful

Readers often search for Hereditary Oncology Molecular Testing For Solid Tumors because they want a clearer explanation, related examples, and a practical way to continue exploring the topic.

Sponsored

Frequently Asked Questions

How should readers use this information?

Use it as a starting point, then open related pages for more specific details.

What should readers check next?

Readers should check related pages, official references, or updated sources when details matter.

Why are related topics included?

Related topics help readers compare nearby references and understand the broader subject.

Reference Gallery

Hereditary oncology: Molecular testing for solid tumors
NGS Testing for Solid Tumors: How It Works at HNL Lab Medicine
From Biomarker Testing to Treatment: Precision Medicine for Solid Tumors (Genomic Testing)
Tumor Testing/Germline Significance
Tumor Molecular Testing—Making Sense of New Precision Medicine Testing Options for Cancer
NGS for precision oncology in solid tumors: from research to clinical practice
Tell Me More: Pharmacogenomics
Genetic Testing and Biomarkers in Cancer: A Community Oncology Approach
Comparative analysis of RNA expression identifies druggable targets in pediatric solid tumors
Archive: Cancer Genetic Testing at the Crossroads
Sponsored
View Full Details
Hereditary oncology: Molecular testing for solid tumors

Hereditary oncology: Molecular testing for solid tumors

In this episode of Lab Medicine Rounds, Sounak Gupta, M.B.B.S., Ph.D., assistant professor of Laboratory Medicine and ...

NGS Testing for Solid Tumors: How It Works at HNL Lab Medicine

NGS Testing for Solid Tumors: How It Works at HNL Lab Medicine

At HNL Lab Medicine, we provide next-generation sequencing (NGS)

From Biomarker Testing to Treatment: Precision Medicine for Solid Tumors (Genomic Testing)

From Biomarker Testing to Treatment: Precision Medicine for Solid Tumors (Genomic Testing)

Read more details and related context about From Biomarker Testing to Treatment: Precision Medicine for Solid Tumors (Genomic Testing).

Tumor Testing/Germline Significance

Tumor Testing/Germline Significance

Read more details and related context about Tumor Testing/Germline Significance.

Tumor Molecular Testing—Making Sense of New Precision Medicine Testing Options for Cancer

Tumor Molecular Testing—Making Sense of New Precision Medicine Testing Options for Cancer

Read more details and related context about Tumor Molecular Testing—Making Sense of New Precision Medicine Testing Options for Cancer.

NGS for precision oncology in solid tumors: from research to clinical practice

NGS for precision oncology in solid tumors: from research to clinical practice

Presented By: Nicola Normanno Speaker Biography: Dr. Normanno, MD earned his Medical Doctor Degree in 1988 at the ...

Tell Me More: Pharmacogenomics

Tell Me More: Pharmacogenomics

Program presented by: Porscha Johnson, PharmD, CPGx This video was recorded in June 2023. Visit cscatlanta.org to learn ...

Genetic Testing and Biomarkers in Cancer: A Community Oncology Approach

Genetic Testing and Biomarkers in Cancer: A Community Oncology Approach

Hosted by Banu Arun, MD, and Kurt A. Schalper, MD, PhD. Download the resources + collect credit:

Comparative analysis of RNA expression identifies druggable targets in pediatric solid tumors

Comparative analysis of RNA expression identifies druggable targets in pediatric solid tumors

Comparative analysis of RNA expression identifies druggable targets in difficult-to-treat pediatric

Archive: Cancer Genetic Testing at the Crossroads

Archive: Cancer Genetic Testing at the Crossroads

Genomic sequencing technologies have enabled increasing use of